The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach that begins with a patient-centric mindset, coupled with the use of mobile technology and connected health platforms, will enable research to become less reliant on site-based visits and bring equal access to new investigational therapies for all patients, regardless of geography, ethnicity, sex, or gender.
In this white paper, you will learn about:
- The current diversity gap and limitations in clinical research
- Barriers for underrepresented patient populations
- Breaking barriers with patient-centric approaches and advanced technology
- Foundations for a new clinical research model
- Engaging and protecting patients with technology
Explore related content and topics
Page
Healthcare Intelligence
Some people focus on their IQ—their intellectual and expertise-driven strategy. Others focus on their EQ—their ability to empathetically relate to…
Case Study
Achieving Challenging Recruitment Goals and Timelines in a Pediatric Type 2 Diabetes Study
Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face…
Page
Immunology
We are experienced therapeutic professionals delivering expertise, effective leadership, and strategic operational services to immunology clinical…